Announced details
Obstetrics and gynecology, delivery settings, perinatal care, medical record creation, and reducing the workload of healthcare professionals
AI,Inc. jointly applied to GENIAC-PRIZE with Medliss and the medical corporation operating an obstetrics and gynecology practice. The application combines Medliss's medical AI platform with AI,Inc.'s speech recognition technology and domestic foundation model. AI,Inc. provides speech synthesis and speech recognition technologies using edge processing. Capital and personnel relationships are Not disclosed.
Medliss is headquartered at 3F, Akasaka Front Town, 4-8-19 Akasaka, Minato-ku, Tokyo. It was established in June 2025, and its representative director is Nakata Kengo (中田 健吾). The company researches, develops and provides medical AI systems and develops and supports the operation of AI agents for obstetrics and gynecology. The Ministry of Economy, Trade and Industry and NEDO are the organizers of GENIAC-PRIZE. The name and location of the medical corporation are not disclosed.
GENIAC-PRIZE (name of the program applied to; award history is Not disclosed)
Ministry of Economy, Trade and Industry and NEDO (organizers of GENIAC-PRIZE)
Medliss headquarters: 3F, Akasaka Front Town, 4-8-19 Akasaka, Minato-ku, Tokyo. The location of the medical corporation is Not disclosed.
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Voice AI agent centered on an iPad hub, Medliss medical AI platform, AI,Inc.'s speech recognition technology, Domestic foundation model |
| Counterparty | Medliss, Medical corporation operating an obstetrics and gynecology practice, Ministry of Economy, Trade and Industry, NEDO |
| Counterparty overview | Medliss is headquartered at 3F, Akasaka Front Town, 4-8-19 Akasaka, Minato-ku, Tokyo. It was established in June 2025, and its representative director is Nakata Kengo (中田 健吾). The company researches, develops and provides medical AI systems and develops and supports the operation of AI agents for obstetrics and gynecology. The Ministry of Economy, Trade and Industry and NEDO are the organizers of GENIAC-PRIZE. The name and location of the medical corporation are not disclosed. |
| Relationship with the Company | AI,Inc. jointly applied to GENIAC-PRIZE with Medliss and the medical corporation operating an obstetrics and gynecology practice. The application combines Medliss's medical AI platform with AI,Inc.'s speech recognition technology and domestic foundation model. AI,Inc. provides speech synthesis and speech recognition technologies using edge processing. Capital and personnel relationships are Not disclosed. |
| Applicable area | Obstetrics and gynecology, delivery settings, perinatal care, medical record creation, and reducing the workload of healthcare professionals |
| Award/certification name | GENIAC-PRIZE (name of the program applied to; award history is Not disclosed) |
| Awarding / certifying body | Ministry of Economy, Trade and Industry and NEDO (organizers of GENIAC-PRIZE) |
| Location | Medliss headquarters: 3F, Akasaka Front Town, 4-8-19 Akasaka, Minato-ku, Tokyo. The location of the medical corporation is Not disclosed. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To reduce the burden on healthcare professionals in obstetrics and gynecology who simultaneously observe mothers and infants and prepare medical records, creating an environment in which more time can be devoted to maternal and newborn care.